Skip to content
Aperlena

INFLIXIMAB [100 MG; POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION; VIAL]

Original INFLIXIMAB [100 MG; PÓ P/A CONC P/A SOL P/A PERF; FRS]

Open Contract notice No deadline published
Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

The Aperlena Verdict

Open race

No supplier dominates: 99 different companies have won the last 228 comparable contracts from this buyer over 5 years. This is a genuinely open race.

0%
Expected final price vs the published estimate

Based on 228 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

This tender covers the supply of the medicinal product Infliximab, presented as 100 mg powder for concentrate for solution for infusion in vials. Infliximab is a biological medicine used in hospital settings, typically for the treatment of chronic inflammatory conditions, and it is administered by infusion after reconstitution and dilution. The procurement concerns the purchase of this pharmaceutical in the stated presentation and strength, intended to meet the needs of the contracting authority's healthcare services. The tender notice does not add further details beyond the product specification, so buyers should consult the accompanying procurement documents for the full terms of supply and delivery requirements.

Official source

Source: BASE - Portal dos Contratos Públicos (IMPIC)

Always verify details on the official notice.

Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 3 days ago

The official portal may ask for a free registration before downloading.

More from this buyer

Full buyer profile

40 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
MYLAN, LDA 10 €78,297 Aug 2026
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA 9 €52,186 Jun 2026
ACCORD HEALTHCARE UNIPESSOAL LDA 8 €46,374 Aug 2026
LABESFAL-LAB. ALMIRO, SA. 8 €40,700 Jul 2026
HIKMA FARMACÊUTICA (PORTUGAL) SA. 8 €38,219 Sep 2026

Based on 228 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 228 comparable contracts this buyer awarded in this sector over the last 4 years.

€1,236
Lower quartile
€3,918
Median award
€15,015
Upper quartile

This tender is estimated 538% above that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,152,710
9,894 open across Europe right now 100% below sector average
Buyer track record on Aperlena
897 notices tracked · 259 awarded
€11,857,041 in awarded contracts

Never miss a tender like this

10,467 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close